Coronary artery disease is typically framed as a condition that declares itself in middle age or later — but subclinical arterial calcification in young adults may be silently setting a far grimmer trajectory decades earlier. Understanding who carries this hidden burden, and what it ultimately costs them, has real implications for when and how aggressively preventive cardiology should intervene.
Drawing on the Coronary Artery Calcium (CAC) Consortium — a well-powered dataset of 44,047 adults with no prior cardiovascular disease history — this analysis identified a distinct high-risk phenotype: individuals whose CAC score fell at or above the 90th percentile for their age, sex, and race. Among the 42% of participants who had any detectable calcium, roughly one-third met this advanced-disease threshold. The structural severity was notable: 76.4% of those with advanced CAC had multivessel involvement, compared to only 40.6% in the lower CAC group. Over a mean follow-up of 12.5 years, the advanced group showed coronary heart disease mortality rates nearly eight times higher than those with no CAC at all (0.65 vs. 0.08 per 1,000 person-years). After full multivariable adjustment, the hazard ratio for all-cause mortality was 2.17, while the sub-distribution hazard ratio for CHD death reached 5.45 — a signal that is difficult to dismiss.
This study's value lies partly in its scale and duration, but also in what it adds conceptually. CAC scoring is already recommended for intermediate-risk adults to guide statin decisions, but its application in younger populations remains underutilized. The consortium's findings suggest that percentile-based thresholds — rather than absolute scores alone — may be a more meaningful lens for young adults, where even modest calcium can represent biological age acceleration. The limitation is inherent to any observational cohort: unmeasured confounders, referral bias toward symptomatic or high-risk individuals seeking scans, and the absence of randomized treatment arms. Still, the effect sizes here are large enough that this qualifies as a clinically important, confirmatory-plus-expansive contribution to preventive cardiology, not merely an incremental data point.
